is currently a pharmaceutical consultant at Seventh Street Development Group with over 20 years of large pharma and contract research experience. For ten years, Dr. Newman performed characterization studies on a wide range of pharmaceutical systems at Bristol-Meyers Squibb, covering drug substance and product scale-up from late drug discovery to launch and manufacturing. After that she was at SSCI, Inc. overseeing characterization of API and drug product samples, crystallization and polymorph screens, salt selections, quantitative assays, amorphous projects and problem solving for the pharmaceutical industry. As Vice President of Research and Development at Aptuit, she instituted a company wide R&D initiative over six global sites and covering areas such as API, preclinical (toxicology, safety, pharmacokinetics), formulation, solids, analytical, clinical packaging, and regulatory. She also holds an adjunct faculty position in Industrial and Physical Pharmacy at Purdue University and is a collaborator on forty publications and over 75 technical presentations.